ym 09151-2 has been researched along with norclozapine in 1 studies
| Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (norclozapine) | Trials (norclozapine) | Recent Studies (post-2010) (norclozapine) |
|---|---|---|---|---|---|
| 249 | 6 | 13 | 275 | 41 | 102 |
| Protein | Taxonomy | ym 09151-2 (IC50) | norclozapine (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.4784 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corsini, GU; Maggio, R; Millan, MJ; Novi, F | 1 |
1 other study(ies) available for ym 09151-2 and norclozapine
| Article | Year |
|---|---|
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation.
Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzoxazoles; Carrier Proteins; Chlorocebus aethiops; Clozapine; COS Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Piperazines; Piperidines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Transfection | 2007 |